Advertisement

Neurological disorders in patients with acute renal failure

  • Andrew Davenport
Chapter

Abstract

Patients with rapidly progressive uraemia often become confused, due to a combination of uraemia, electrolyte and acid-base disorders, sepsis, the accumulation of drugs and other organ failure. Some groups with pre-existing renal disease are more prone to neurological complications; cerebral venous thrombosis in patients with the nephrotic syndrome, CNS infection in renal transplant recipients, and subarachnoid haemorrhage in adult polycystic kidney disease. Similarly, the incidence of renal failure is increased in patients with bladder dysfunction; spina bifida and multiple sclerosis.

Keywords

Cerebral Blood Flow Peritoneal Dialysis Acute Renal Failure Cerebral Perfusion Pressure Mean Arterial Blood Pressure 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

References

  1. 1.
    Betz E. Cerebral blood flow: its measurement and regulation. Physiol Rev 1972: 552–95.Google Scholar
  2. 2.
    Baethmann A, Maier-Hauff K, Kempski O, Unterberg A, Wahl M, Schurer L. Mediators of brain oedema and secondary brain damage. Crit Care Med 1988; 16: 972–8.PubMedGoogle Scholar
  3. 3.
    Kontos HA, Wei EP. Oxygen dependent mechanisms in cerebral auto-regulation. Ann Biomed Eng 1985; 13: 329–34.PubMedGoogle Scholar
  4. 4.
    Astrup J, Siesjo BK, Symon L. Thresholds in cerebral ischaemia: the ischaemic penumbra. Stroke 1981; 12: 723–5.PubMedGoogle Scholar
  5. 5.
    Schmidek HH, Auer LM, Kapp JP. The central venous system. Neurosurgery 1985; 17: 663–78.PubMedGoogle Scholar
  6. 6.
    Davenport A, Will EJ, Davison AM. The effect of posture on intracranial pressure in patients with fulminant hepatic failure and oligurie renal failure following paracetamol (acetaminophen) self-poisoning. Crit Care Med 1990; 18: 286–9.PubMedGoogle Scholar
  7. 7.
    Malkison TJ. Veale WL, Cooper KE. Fever and intra-cranial pressures. Brain Res Bulletin 1985; 15: 315–9.Google Scholar
  8. 8.
    Siesjo BK. Mechanisms of ischaemic brain damage. Crit Care Med 1988; 16: 954–63.PubMedGoogle Scholar
  9. 9.
    Gotoh O, Asano T, Koide T, Takakura K. Ischamic brain oedema following occlusion of the middle cerebral artery in the rat. 1. The time course of the brain water, sodium and postassium contents and blood-brain barrier permeability to I125 albumin. Stroke 1985; 16: 101–9.PubMedGoogle Scholar
  10. 10.
    Kagstrom E, Smith M-L, Siesjo BK. Recirculation in the rat brain following incomplete ischaemia. J Cereb Blood Flow Metab 1983; 3: 183–92.PubMedGoogle Scholar
  11. 11.
    Ede RJ, Gimson AES, Bihari D, Williams R Controlled hyper-ventilation in the prevention of cerebral oedema in fulminant hepatic failure. J Hepatol 1986; 2: 43–51.PubMedGoogle Scholar
  12. 12.
    Procter HJ, Cairns C, Fillipo D, Palladino GW, Rosner MJ. Brain metabolism during increased intracranial pressure as assessed by niroscopy. Surgery 1984; 96: 273–9.Google Scholar
  13. 13.
    Tyler HR. Neurologic disorders in renal failure. Am J Med 1968; 44: 734–8.PubMedGoogle Scholar
  14. 14.
    Niiro M, Kadota K, Asakura T, Simon RP. Changes in cerebral extracellular pH, cerebral blood flow and intracranial pressure induced by hypercarbic ventilation-assessment as a potential in vivo model of cerebral acidosis. No To Shinkei 1994; 46: 639–45.PubMedGoogle Scholar
  15. 15.
    Scheinberg P. Effects of uraemia on cerebral blood flow and metabolism. Neurology 1954; 4: 101–5.PubMedGoogle Scholar
  16. 16.
    Bowton DL, Bertels NH, Prough DS, Stum DA. Cerebral blood flow is reduced in patients with sepsis syndrome. Crit Care Med 1989; 17: 399–403.PubMedGoogle Scholar
  17. 17.
    Guisado R, Arietf Al, Massry SG, Lazarowitz V, Kerian A. Changes in the EEG in acute uraemia: effects of PTH and brain electrolytes. J Clin Invest 1975; 55: 738–45.PubMedGoogle Scholar
  18. 18.
    Ramachandran S, Ganaikabahu B, Pushparajan K, Wijesekera J. EEG abnormalities in patients with snake bites. Am J Trop Med Hyg 1995; 52: 25–8.PubMedGoogle Scholar
  19. 19.
    Nau HE, Rimpel J. Multimodality evoked potentials and electroencephalography in severe coma cases. Intensive Care Med 1987; 13: 249–55.PubMedGoogle Scholar
  20. 20.
    Davenport A, Bramley PN. Cerebral function analysing monitor and visual evoked potentials as a noninvasive method of detecting cerebral dysfunction in patients with acute hepatic and renal failure treated with intermittent machine haemofiltration. Ren Fail 1993; 15: 515–22.PubMedGoogle Scholar
  21. 21.
    Haranomura H, Takeyama Y, Toyokawa A, Saito Y. Possible involvement of activation of pulmonary macrophages in respiratory failure with acute pancreatitis. Nippon Geka Gekkai Zasshi 1994; 95; 376–81Google Scholar
  22. 22.
    Davenport A, Goldsmith HJ. Haemofiltration in the management of patients with acute renal failure complicated by raised intracranial pressure. Lancet 1987; i: 216.Google Scholar
  23. 23.
    Bolton CF. Neuropathies in the critical care unit. Br J Hosp Med 1992; 47: 358–60.PubMedGoogle Scholar
  24. 24.
    Latronico N, Fenzi F, Recupero D, Guarneri B, Tomelleri G, Tonin P, DeMaria, G, Antonini L, Rizzuto N, Candiani A. Critical illness myopathy and neuropathy. Lancet 1996; i: 1579–82.Google Scholar
  25. 25.
    Davenport A. Muscle weakness associated with continuous haemofiltration. Intensive Care Med 1989; 15: 328–9.PubMedGoogle Scholar
  26. 26.
    Zochdane DW, Ramasay DA, Saly V, Shelly S, Moffatt S. Acute necrotising myopathy of intensive care: electrophysiological studies. Muscle Nerve 1994; 17: 285–92.Google Scholar
  27. 27.
    Van den Noort S, Eckel RE, Brine K, Hrdlicka JT. Brain metabolism in uraemic and adenosine infused rats. J Clin Invest 1968; 47: 2133–9.Google Scholar
  28. 28.
    Cooper JD. Neurologic abnormalities in patients with acute renal failure. Kidney Int 1976; 10: 556.Google Scholar
  29. 29.
    Fraser CL, Sarnacki P, Arieff AI. Calcium transport abnormality in uraemic rat brain synaptosomes. J Clin Invest 1985; 76: 1789–1883.PubMedGoogle Scholar
  30. 30.
    Biasioli S, D’Andrea G, Chiaramonte S et al. The role of neurotransmitters in the genesis of uraemic encephalopathy. Int J Artif Organs 1984; 7: 101–6.PubMedGoogle Scholar
  31. 31.
    Davenport A, Roberts NB. Amino acid losses during continuous high flux haemofiltration in the critically ill patient. Crit Care Med 1989; 10: 1010–4.Google Scholar
  32. 32.
    Davenport A, King RFJG, Ironside JW, Will. EJ, Davison AM. The effect of treatment with recombinant human erythropoietin on the histological appearance and glycogen content of skeletal muscle in patients with chronic renal failure treated by regular hospital haemodialysis. Nephron 1993; 64: 89–94.PubMedGoogle Scholar
  33. 33.
    Dyck PJ, Thomas PK, Griffin JG, Low PA, Podulso J. Peripheral neuropathy 3rd edition. WB Saunders, Philadelphia, USA 1993; 1–25.Google Scholar
  34. 34.
    Tomlinson BE, Pierides AM, Bradley WG. Central pontine myelinolysis: two cases with associated electrolyte disturbance. Q J Med 1976; 65: 373–7.Google Scholar
  35. 35.
    Bartholomew LG, Scholz DA. Reversible postoperative neurological. syndromes. JAMA 1956; 22: 831–3.Google Scholar
  36. 36.
    Clark EC, Thomas D, Baer J, Sterns RH. Depletion of glutathione from brain cells in hyponatraemia. Kidney Int 1996; 49: 447–76.Google Scholar
  37. 37.
    Boon AP, Carey MP, Salmon MV. Central pontine mylelinolysis is not associated with rapid correction of hyponatraemia. Lancet 1988; ii: 458.Google Scholar
  38. 38.
    Estol CJ, Faris AA, Martinez AJ, Barmada DDA. Central pontine myelinolysis after liver transplantation. Neurology 1989; 39: 493–6.PubMedGoogle Scholar
  39. 39.
    Ayus JC, Krothapalli RK, Arieff M. Treatment of symptomatic hyponatraemia and its relation to brain damage: a prospective study. N Engl J Med 1987; 317: 1190–3.PubMedGoogle Scholar
  40. 40.
    Arieff AL. Management of hyponatraemia. Br Med J 1993; 307: 305–6.Google Scholar
  41. 41.
    Lamer AJ, Vickers CR, Adu D, Bukels JD, Elias E, Neuberger J. Correction of severe hyponatremia by continuous arteriovenous haemofiltration before liver transplantation. Br Med J 1988; 297: 1514–5.Google Scholar
  42. 42.
    Cserr HF, DePasquale M, Patlak CS. Regulation of brain water and electrolytes during acute hyperosmolality in rats. Am J Physiol 1987; 253: F522–7.PubMedGoogle Scholar
  43. 43.
    Betz E, Heuser D. Actions and interactions of cations and anions on pial arteries. Cervos-Navarro J (ed) Advances in Neurology, Raven Press, New York 1978; 20: 390–6.Google Scholar
  44. 44.
    Davenport A, Worth DP, Will EJ. Hypochloraemic alkalosis after high flux continuous haemofiltration and continuous arteriovenous haemofiltration with dialysis. Lancet 1988; i: 658.Google Scholar
  45. 45.
    Walser M. Ion association. VI. Interactions between calcium, magnesium, inorganic phosphate, citrate and protein in normal human plasma. J Clin Invest 1961; 40: 723–30.PubMedGoogle Scholar
  46. 46.
    Kanis JA. Disorders of calcium metabolism. In: Weatherall DJ, Ledingham JGG, Warrell DA (eds). Oxford Textbook of Medicine, 3rd edition. Oxford University Press 1996, 1622–39Google Scholar
  47. 47.
    Davenport A, Goel S, Mackenzie JC. Treatment of hypercalcaemia with pamidronate in patients with end-stage renal failure. Scand J Urol Nephrol 1993; 27: 447–51.PubMedGoogle Scholar
  48. 48.
    Davenport A, Will EJ. Hypophosphataemia in acute liver failure. Br Med J 1988; 296: 131.Google Scholar
  49. 49.
    Lam CN, McNeish AS, Gibson AMM. Nephrotic syndrome associated with. complement deficiency and staphylococcal albus bacteraemia. Scot Med J 1969; 14: 86–8.PubMedGoogle Scholar
  50. 50.
    Davenport A, Dealler SF. The epidermo-peritoneal potential in patients treated with continuous ambulatory peritoneal dialysis. Int J Artif Organs 1993; 16: 71–4.PubMedGoogle Scholar
  51. 51.
    Zunin C, Castellani A, Olivetti G, Marini G, Gabriele PW. Membranoproliferative glomerulonephritis associated with infected ventriculoatrial shunt: report of two cases recovered after removal of shunt. Pathologica 1977; 69: 27–305.Google Scholar
  52. 52.
    Partriarca PA, Lauer BA. Ventriculoperitonal shunt associated infection due to Haemophilus influenzae. Paediatr 1980; 65: 1007–9.Google Scholar
  53. 53.
    Humphreys MH. Human immunodeficiency virus-associated glomerulosclerosis. Kidney Int 1995, 48: 3 1120.Google Scholar
  54. 54.
    Detwiler RK, Falk RJ, Hogan SL, Jennette JC. Collapsing glomerulopathy: a clinically and pathologically distinct variant of focal segmental glomerulosclerosis. Kidney Int 1994; 45: 1416–24.PubMedGoogle Scholar
  55. 55.
    Davenport A, Goel S, Mackenzie JC. Neurotoxicity of acyclovir in patients with end-stage renal failure treated with continuous ambulatory peritoneal dialysis (CAPD). Am J Kidney Dis 1992; 20: 647–9.PubMedGoogle Scholar
  56. 56.
    Morgan O StC, Rodgers-Johnson P, Mora C, Char G. HTLV-1 and polymyositis in Jamaica. Lancet 1989; ii: 1184–7.Google Scholar
  57. 57.
    Fahal IH, Murray N, Chu P, Bell GM. Acute renal failure during interferon treatment. Br Med J 1993; 306: 973.Google Scholar
  58. 58.
    Parke MG, Atkinson B, Ucci A, Levey AS. Rapidly progressive glomerulonephritsis after immunotherapy for cancer. J Am Soc Nephrol 1995; 5: 1740–4.Google Scholar
  59. 59.
    Whiteneck, GG, Adler C, Carter RE, Wagner KA. Mortality, morbidity and pyschosocial outcomes of persons with spinal cord injured more than 20 years ago. Paraplegia 1992; 30: 617–30.PubMedGoogle Scholar
  60. 60.
    Bannister CM, Tew B (ed). Current concepts in spina bifida and hydrocephalus. Mac Keith Press, London, UK 1991; 46–58.Google Scholar
  61. 61.
    Joseph DB, Bauer SB, Colodny AH, Mandell J, Retik AB. Clean, intermittent catheterisation of infants with neurogenic bladder. Paediatr 1989; 84: 78–82.Google Scholar
  62. 62.
    Rosenberg H. Clinical presentation of malignant hyperthermia. Br J Anaesthes 1988; 60: 268–73.Google Scholar
  63. 63.
    Willner JH, Cern CJ, Wood DS. Malignant hyperthermia: abnormal cyclic AMP metabolism in skeletal muscle. Neurology 1979; 29: 557–63.Google Scholar
  64. 64.
    Velamoor VR. Progression of symptoms in neuroleptic malignant syndrome. J Nerve Mental Dis 1994; 182: 168–73.Google Scholar
  65. 65.
    Hawkins DA. Physical complications of drug abuse. In: Weatherall DJ, Ledingham JGG, Warrell DA (eds). Oxford Textbook of Medicine, 3rd edition. Oxford University Press 1996, 4280.Google Scholar
  66. 66.
    Winney RJ, Kean DM, Best JJK, Smith MA. Changes in brain water with dialysis. Lancet 1986; 11: 1107–8.Google Scholar
  67. 67.
    Davenport A, Finn R, Goldsmith HJ. Management of patients with renal failure complicated by cerebral oedema. Blood Purif 1989; 7: 203–9.PubMedGoogle Scholar
  68. 68.
    Kennedy AC, Linton AL, Eaton JC. Urea levels in cerebrospinal fluid after haemodialysis. Lancet 1962; i: 410–11.Google Scholar
  69. 69.
    Arieff AI. Dialysis disequilibrium syndrome: current concepts on pathogenesis and prevention. Kidney Int 1994; 44: 629–35.Google Scholar
  70. 70.
    Rosen SM, O’Connor K, Shaldon S. Haemodialysis disequilibrium. Br Med J 1964; 2: 672–5.PubMedGoogle Scholar
  71. 71.
    Pappius HM, Oh JH, Dossetor JB. The effects of rapid haemodialysis on brain tissues and cerebrospinal fluid of dogs. Can J Physiol 1967; 45: 129–47.Google Scholar
  72. 72.
    Arieff AI, Guisado R, Massry SG, Lazarowitz VC. Central nervous system pH in uraemia and the effects of haemodialysis. J Clin Invest 1976; 58: 306–11.PubMedGoogle Scholar
  73. 73.
    Wilkinson SP, Weston MJ, Parsons V, Williams R. Dialysis in the treatment of renal failure in patients with liver disease. Clin Nephrol 1977; 8: 287–92.PubMedGoogle Scholar
  74. 74.
    Gilliland KG, Hegstrom RM. The effect of haemodialysis on cerebrospinal fluid pressure in uraemic dogs. Trans Am Soc Artif Intern Organs 1963; 9: 44–50.PubMedGoogle Scholar
  75. 75.
    Peterson H deC, Swanson AG. Acute encephalopathy occurring during haemodialysis. Arch Intern Med 1964; 113: 877–80.PubMedGoogle Scholar
  76. 76.
    Randall RE Jr, Singh R, Laster J, Belle C, Setter JG. Increased intracranial pressure from unsustained levels of plasma mannitol during haemodialysis. J Lab Clin Med 1967; 70: 129–37.PubMedGoogle Scholar
  77. 77.
    Leonard A, Shapiro F. Subdural haematoma in regularly haemodialysed patients. Ann Intern Med 1975; 82: 650–8.PubMedGoogle Scholar
  78. 78.
    Weber DL, Reagan T, Leeds M. Intracerbral haemorrhage during haemodialysis. New York State J Med 1972; 7: 1853–4.Google Scholar
  79. 79.
    Giammarco RA, Goldberg F. Intracranial pressure monitoring during haemodialysis. Int J Paediatr Nephrol 1981; 2: 197–200.Google Scholar
  80. 80.
    Bertrand YM, Hermant A, Mahieu P, Roels J. Intracranial pressure changes in patients with head trauma during haemodialysis. Intensive Care Med 1983; 9: 321–3.PubMedGoogle Scholar
  81. 81.
    Yoshida S, Tajika T, Yamasaki N, Tanikawa T, Kitamura K, Kubo K, Lyden PD. Dialysis disequilibrium syndrome in neurosurgical patients. Neurosurgery 1987; 20: 716–21.PubMedGoogle Scholar
  82. 82.
    Kopitnik TA, deAndrade R, Gold MA, Nugent GR. Pressure changes within a chronic subdural haematoma during haemodialysis. Surg Neurol 1989; 32: 289–93.PubMedGoogle Scholar
  83. 83.
    Usui Y, Tamaki SI, Hashizume M, Mukoyama M, Matuo T. A case with chronic renal haemodialysis and intracranial hypertension: a study on CSF dynamics 1989; 4: 397–404.Google Scholar
  84. 84.
    Krane NK. Intracranial pressure measurement in a patient undergoing haemodialysis and peritoneal dialysis. Am J Kid Dis 1989; 13: 336–9.PubMedGoogle Scholar
  85. 85.
    Gondo G, Fujitsu K. Kuwabara T, Mochimtitsu Y, Ishiwata Y, Oda H, Takagi N, Yamashita T, Fujino H, Kim I, Nakajima F. Comparison of five modes of dialysis in neurosurgical patients with renal failure. Neurol Med Chir (Tokyo) 1989; 29: 1125–31.Google Scholar
  86. 86.
    Hirano K, Ishii R, Suzuki Y, Kikuoka M, Hirano H, Ohsawa G, Ohtsuka R. Itoh Y. Neurosurgical management of dialyzed patients. Neurol Med Chir (Tokyo) 1991; 31: 899–904.Google Scholar
  87. 87.
    Silk DBA, Trewby PN, Chase RA, Mellon PJ, Hanid MA, Davies M, Langley PG, Wheeler PG, Williams R. Treatment of fulminant hepatic failure by polyacrylonitrile membrane haemodialysis. Lancet 1977; ii: 1–3.Google Scholar
  88. 88.
    Lee WM. Acute liver failure. Am J Med 1994; 96: suppl IA: 3S–9S.PubMedGoogle Scholar
  89. 89.
    Bidwell G, Sherrard D, Mathews M. Peritoneal dialysis: a temporizing means for haemodialysis patients with subdural haematomas. Nephron 1977; 18: 352–3.PubMedGoogle Scholar
  90. 90.
    Mactier RA, Dobbie JW, Khanna R. Peritoneal dialysis in fulminant hepatic failure. Perit Dial Bull 1986; 4: 199–202.Google Scholar
  91. 91.
    Davenport A. Continuous forms of haemofiltration and dialysis in patients with liver failure. Am J Kidney Dis 1996; 28: 562–7.Google Scholar
  92. 92.
    Gotloib L, Mines M, Garmzo L, Varka I. Hiemodynamic effects of increasing intra-abdominal pressure in peritoneal dialysis. Perit Dial Bull 1981; 1: 41–3.Google Scholar
  93. 93.
    Bunchman TE, Meldrum MK, Meliones JE, Sedman AB, Walters MB, Kershaw DB. Pulmonary function variation in ventilator dependent critically ill infants on peritoneal dialysis. Adv Perit Dial 1992; 5: 75–8.Google Scholar
  94. 94.
    Mutimer DJ, Burra P, Neuberger JM, Hubsher S, Buckets JAC, Mayer AD, McMaster P, Elias E. Managing severe alcoholic hepatitis complicated by renal failure. Q J Med 1993; 86: 649–56.PubMedGoogle Scholar
  95. 95.
    Kishimoto T, Yamagami S, Tanaka H, Ohyima T, Yamamoto T, Yamakawa M, Nishino M, Yoshimoto S, Maekawa M. Superiority of haemofiltration to haemodialysis for treatment of chronic renal failure: comparative studies between haemofiltration and haemodialysis on dialysis disequilibrium syndrome. J Artif Organs 1980; 4: 86–93.Google Scholar
  96. 96.
    Quellhorst EA, Schuenemann B, Hildebrand U, Falda Z. Response of the vascular system to different modifications of haemofiltration and haemo-dialysis. Proc EDTA 1980; 17: 197–204.Google Scholar
  97. 97.
    Davenport A, Will EJ, Davison AM. Early changes in intracranial pressure during haemofiltration treatment in patients with grade IV hepatic encephalopathy and acute oliguric renal failure. Nephrol Dial Transplant 1990; 5: 192–8.PubMedGoogle Scholar
  98. 98.
    Davenport A, Will EJ, Davison AM. Effect of renal replacement therapy on patients with combined acute renal and fulminant hepatic failure. Kidney Int 1993; 43: Suppl 41: 5245–51.Google Scholar
  99. 99.
    Kramer P, Wigger W, Rieger J, Mathaei D, Cheler F. Arteriovenous haemofiltration: a new and simple method for the treatment of overhydrated patients resistant to diuretics. Klin Wschr 1977; 55: 1121–2.PubMedGoogle Scholar
  100. 100.
    Davenport A, Will EJ, Losowsky MS, Swindells S. Continuous arteriovenous haemofiltration in patients with hepatic encephalopathy and renal failure. Br Med J 1987; 295: 1028.Google Scholar
  101. 101.
    Rakela J, Kurtz SB, McCarthy JT, Krom RAF, Baldus WP, Mcrill DB, Perrault J, Milliner DS. Postdilution hemofiltration in the management of acute hepatic failure: a pilot study. Mayo Clin Proc; 1988; 63: 113–8.PubMedGoogle Scholar
  102. 102.
    Trottier SJ, Veremakis C, O’Brien J, Auer AI. Femoral deep vein thrombosis associated with central venous catheterisation: results from a prospective, randomized trial. Crit Care Med 1995; 23: 2–59.Google Scholar
  103. 103.
    Storck M, Hartl WH, Zimmerer E, Inthorn D. Comparison of pump-driven and spontaneous continuous haemofiltration in postoperative acute renal failure. Lancet 1991; 337: 452–5.PubMedGoogle Scholar
  104. 104.
    Dyson EH, Johnston P, Prabhu P, Goutcher E, Davison AM, Will EJ. Volumetric control of continuous haemodialysis in multiorgan failure. Artif Organs 1991; 16: 439–42.Google Scholar
  105. 105.
    Lazarus JM, Owen WF. Role of bioincompatibility in dialysis morbidity and mortality. Am J Kidney Dis 1994; 24: 1019–32.PubMedGoogle Scholar
  106. 106.
    Schiffl H, Lang SM, König A, Strass T, Haider MC, Held E. Biocompatible membranes in acute renal failure: prospective case controlled study. Lancet 1994; 344: 570–772.PubMedGoogle Scholar
  107. 107.
    Davenport A, Will EJ, Davison AM. Membrane biocompatibility: effects on cardiovascular stability in patients on haemofiltration. Kidney Int 1993; 43: (suppl 41): S230–4.Google Scholar
  108. 108.
    Gueugniaud PY, Bertin-Maghit M, Hirschaner C, Petit P. Removal of cytokines in septic patients using continuous veno-venous haemofiltration. Crit Care Med 1994; 22: 717.PubMedGoogle Scholar
  109. 109.
    Davenport A, Will EJ, Davison AM. Comparison of the use of standard heparin and prostacyclin anticoagulation in spontaneous and pump-driven extracorporeal circuits in patients with combined acute renal failure and hepatic failure. Nephron 1994; 66: 431–7.PubMedGoogle Scholar
  110. 110.
    Jeffrey RF, Khan AA, Douglas JT, Will EJ, Davison AM. Anticoagulation with low molecular weight heparin (fragmin) during continuous haemodialysis in the intensive care unit. Artif Organs 1993; 17: 717–20.PubMedGoogle Scholar
  111. 111.
    Ohtake Y, Hirasawa H, Sugai T, Oda S, Shiga H, Matsuda K, Kitamura N. Nafamostat mesylate as anticoagulant in continuous haemofiltration and continuous haemodiafiltration. Contrib Nephrol 1991; 93: 215–7.PubMedGoogle Scholar
  112. 112.
    Mehta, RL, McDonald BR, Ward DM. Regional citrate anticoagulation for continuous arteriovenous haemodialysis. Contrib Nephrol 1991; 93: 210–4.PubMedGoogle Scholar
  113. 113.
    Flanigan MJ, Pillsbury L, Sadewasser G, Lim VS. Regional haemodialysis anticoagulation: hypertonic trisodium citrate or anticoagulant citrate dextose-A. Am J Kidney Dis 1996; 27: 519–24.PubMedGoogle Scholar
  114. 114.
    Wendon JA, Harrison PM, Keays R, Gimson AES, Alexander GJM, Williams R. Effects of vasopressor agents and epoprostenol on systemic haemodynamics and oxygen transport in fulminant hepatic failure. Hepatol 1992; 15: 1067–71.Google Scholar
  115. 115.
    Bellomo R, Teede H, Boyce N. Anticoagulant regimens in acute continuous haemodiafiltration: a comparative study. Intensive Care Med 1993; 19: 329–32.PubMedGoogle Scholar
  116. 116.
    Gretz N, Quintel M, Ragaller M, Odenwaldter W, Bender HJ, Rohmeiss P, Strauch M. Low-dose heparinisation for anticoagulation in intensive care patients on continuous haemofiltration. Contrib Nephrol 1991; 116: 130–5.Google Scholar
  117. 117.
    Veech RL, Fowler RC. Cerebral dysfunction and respiratory alkalosis during peritoneal dialysis with D-lactate containing dialysis fluid. Am J Med 1986; 82: 572–3.Google Scholar

Copyright information

© Springer Science+Business Media Dordrecht 1998

Authors and Affiliations

  • Andrew Davenport

There are no affiliations available

Personalised recommendations